The full agenda will be available soon.

The agenda will offer a dynamic blend of clinical updates and engaging debates on groundbreaking scientific topics. Experts will explore emerging concepts and therapies across multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, myeloid malignancies, and more.
 

Agenda Highlights:

• Latest Advances in Bispecific Antibody Therapy – Exploring cutting-edge treatments across hematologic malignancies
• Optimizing Combination Therapy – Strategies to enhance treatment efficacy and patient outcomes
• Sequencing Treatment Strategies – CAR-T, Bispecifics, Novel Agents: What to administer and when?